SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
To donate by check, phone, or other method, see our More Ways to Give page.
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation on Wednesday. (Image: Social Security Works)
The U.S. Senate on Wednesday, with the help of crucial votes by Democrats, confirmed former Eli Lilly executive Alex Azar to become the nation's top healthcare administrator, provoking ire among progressives and healthcare advocates.
\u201cShame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry: https://t.co/b4Gqxvwedv\u201d— Social Security Works (@Social Security Works) 1516826042
Notable on the rollcall list, and the source of ire among critics, was the fact that six Democratic Senators--Doug Jones of Alabama, Tom Carper of Delaware, Chris Coons of Delaware,Joe Donnelly of Indiana, Heidi Heitkamp of North Dakota, and Joe Manchin of West Virginia --joined with Republicans and voted in favor. With the addition of Sen. Angus King, the Indepedent from Maine who caucuses with the Democrats, that gave Azar the needed support to be confirmed.
\u201cDemocrats provided the margin of victory for Azar, would have been 48-50 if Dems all voted no https://t.co/UFH9GRsf9n\u201d— David Dayen (@David Dayen) 1516837759
\u201cUS Senate voted 55 to 43 to make @LillyPad CEO Alex Azar head of @HHSGov. \n\nWhich Democrats helped Repubs approve this greedy #BigPharma CEO?\n\n@SenatorCarper - DE\n@ChrisCoons - DE\n@SenDonnelly - IN\n@SenatorHeitkamp - ND\n@GDouglasJones - AL\n@Sen_JoeManchin - WV\n\n#WeWantBetterDems\u201d— RoseAnn DeMoro (@RoseAnn DeMoro) 1516843300
President Donald Trump nominated Azar after his first Health and Human Services Secretary Tom Price was forced to resign last year following revelations he was using taxpayer money to charter private plans for unnecessary trips.
While opponents of his nomination, including advocacy groups like Public Citizen, mounted an aggressive campaign to block Azar's confirmation, in the end it was not enough.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation. "If Azar's record of corruption is any indication of his future behavior, his tenure will be even shorter than his predecessor Tom Price."
Donald Trump’s attacks on democracy, justice, and a free press are escalating — putting everything we stand for at risk. We believe a better world is possible, but we can’t get there without your support. Common Dreams stands apart. We answer only to you — our readers, activists, and changemakers — not to billionaires or corporations. Our independence allows us to cover the vital stories that others won’t, spotlighting movements for peace, equality, and human rights. Right now, our work faces unprecedented challenges. Misinformation is spreading, journalists are under attack, and financial pressures are mounting. As a reader-supported, nonprofit newsroom, your support is crucial to keep this journalism alive. Whatever you can give — $10, $25, or $100 — helps us stay strong and responsive when the world needs us most. Together, we’ll continue to build the independent, courageous journalism our movement relies on. Thank you for being part of this community. |
The U.S. Senate on Wednesday, with the help of crucial votes by Democrats, confirmed former Eli Lilly executive Alex Azar to become the nation's top healthcare administrator, provoking ire among progressives and healthcare advocates.
\u201cShame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry: https://t.co/b4Gqxvwedv\u201d— Social Security Works (@Social Security Works) 1516826042
Notable on the rollcall list, and the source of ire among critics, was the fact that six Democratic Senators--Doug Jones of Alabama, Tom Carper of Delaware, Chris Coons of Delaware,Joe Donnelly of Indiana, Heidi Heitkamp of North Dakota, and Joe Manchin of West Virginia --joined with Republicans and voted in favor. With the addition of Sen. Angus King, the Indepedent from Maine who caucuses with the Democrats, that gave Azar the needed support to be confirmed.
\u201cDemocrats provided the margin of victory for Azar, would have been 48-50 if Dems all voted no https://t.co/UFH9GRsf9n\u201d— David Dayen (@David Dayen) 1516837759
\u201cUS Senate voted 55 to 43 to make @LillyPad CEO Alex Azar head of @HHSGov. \n\nWhich Democrats helped Repubs approve this greedy #BigPharma CEO?\n\n@SenatorCarper - DE\n@ChrisCoons - DE\n@SenDonnelly - IN\n@SenatorHeitkamp - ND\n@GDouglasJones - AL\n@Sen_JoeManchin - WV\n\n#WeWantBetterDems\u201d— RoseAnn DeMoro (@RoseAnn DeMoro) 1516843300
President Donald Trump nominated Azar after his first Health and Human Services Secretary Tom Price was forced to resign last year following revelations he was using taxpayer money to charter private plans for unnecessary trips.
While opponents of his nomination, including advocacy groups like Public Citizen, mounted an aggressive campaign to block Azar's confirmation, in the end it was not enough.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation. "If Azar's record of corruption is any indication of his future behavior, his tenure will be even shorter than his predecessor Tom Price."
The U.S. Senate on Wednesday, with the help of crucial votes by Democrats, confirmed former Eli Lilly executive Alex Azar to become the nation's top healthcare administrator, provoking ire among progressives and healthcare advocates.
\u201cShame on every Senator who voted to put pharma exec Alex Azar, who has a long history of putting profits over people, in charge of regulating the health care industry: https://t.co/b4Gqxvwedv\u201d— Social Security Works (@Social Security Works) 1516826042
Notable on the rollcall list, and the source of ire among critics, was the fact that six Democratic Senators--Doug Jones of Alabama, Tom Carper of Delaware, Chris Coons of Delaware,Joe Donnelly of Indiana, Heidi Heitkamp of North Dakota, and Joe Manchin of West Virginia --joined with Republicans and voted in favor. With the addition of Sen. Angus King, the Indepedent from Maine who caucuses with the Democrats, that gave Azar the needed support to be confirmed.
\u201cDemocrats provided the margin of victory for Azar, would have been 48-50 if Dems all voted no https://t.co/UFH9GRsf9n\u201d— David Dayen (@David Dayen) 1516837759
\u201cUS Senate voted 55 to 43 to make @LillyPad CEO Alex Azar head of @HHSGov. \n\nWhich Democrats helped Repubs approve this greedy #BigPharma CEO?\n\n@SenatorCarper - DE\n@ChrisCoons - DE\n@SenDonnelly - IN\n@SenatorHeitkamp - ND\n@GDouglasJones - AL\n@Sen_JoeManchin - WV\n\n#WeWantBetterDems\u201d— RoseAnn DeMoro (@RoseAnn DeMoro) 1516843300
President Donald Trump nominated Azar after his first Health and Human Services Secretary Tom Price was forced to resign last year following revelations he was using taxpayer money to charter private plans for unnecessary trips.
While opponents of his nomination, including advocacy groups like Public Citizen, mounted an aggressive campaign to block Azar's confirmation, in the end it was not enough.
"Shame on every Senator who voted to put big pharma CEO Alex Azar, who colluded to triple the price of insulin, in charge of regulating the health care industry," said Alex Lawson, executive director of Social Security Works, in response to the confirmation. "If Azar's record of corruption is any indication of his future behavior, his tenure will be even shorter than his predecessor Tom Price."